American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update.
Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D.
J Oral Maxillofac Surg. 2022 May;80(5):920-943. doi: 10.1016/j.joms.2022.02.008. Epub 2022 Feb 21.
Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS.
Anastasilakis AD, Pepe J, Napoli N, Palermo A, Magopoulos C, Khan AA, Zillikens MC, Body JJ.
J Clin Endocrinol Metab. 2022 Apr 19;107(5):1441-1460. doi: 10.1210/clinem/dgab888.
Relationship between tooth extraction and development of medication-related osteonecrosis of the jaw in cancer patients.
Soutome S, Otsuru M, Hayashida S, Murata M, Yanamoto S, Sawada S, Kojima Y, Funahara M, Iwai H, Umeda M, Saito T.
Sci Rep. 2021 Aug 26;11(1):17226. doi: 10.1038/s41598-021-96480-8.
Teriparatide Promotes Bone Healing in Medication-Related Osteonecrosis of the Jaw: A Placebo-Controlled, Randomized Trial.
Sim IW, Borromeo GL, Tsao C, Hardiman R, Hofman MS, Papatziamos Hjelle C, Siddique M, Cook GJR, Seymour JF, Ebeling PR.
J Clin Oncol. 2020 Sep 10;38(26):2971-2980. doi: 10.1200/JCO.19.02192. Epub 2020 Jul 2.
Systematic review of medication related osteonecrosis of the jaw (MRONJ) in patients undergoing only antiangiogenic drug therapy: surgery or conservative therapy?
Sacco R, Woolley J, Patel G, Calasans-Maia MD, Yates J.
Br J Oral Maxillofac Surg. 2022 Feb;60(2):e216-e230. doi: 10.1016/j.bjoms.2021.03.006. Epub 2021 Mar 24.
Medication-Related Osteonecrosis of the Jaw.
Chen YF, Chang HP.
N Engl J Med. 2023 May 25;388(21):e69. doi: 10.1056/NEJMicm2209172. Epub 2023 May 20.
Medication-related osteonecrosis (MRONJ) of the mandible and maxilla.
Dunphy L, Salzano G, Gerber B, Graystone J.
BMJ Case Rep. 2020 Jan 5;13(1):e224455. doi: 10.1136/bcr-2018-224455.
The Role of the Immune Response in the Development of Medication-Related Osteonecrosis of the Jaw.
Zhang W, Gao L, Ren W, Li S, Zheng J, Li S, Jiang C, Yang S, Zhi K.
Front Immunol. 2021 Feb 25;12:606043. doi: 10.3389/fimmu.2021.606043. eCollection 2021.
Osteonecrosis of the jaw associated with pembrolizumab.
Pennings I, Moskowitz A, Shah G, Estilo C, Huryn JM, Yom SK.
Oral Surg Oral Med Oral Pathol Oral Radiol. 2023 Jul;136(1):e11-e14. doi: 10.1016/j.oooo.2022.12.013. Epub 2023 Jan 1.
Pathophysiology of osteonecrosis of the jaw in patients treated with bisphosphonate.
Badel T, Pavicin IS, Carek AJ, Rosin-Grget K, Grbesa D.
Coll Antropol. 2013 Jun;37(2):645-51.
